View all IQVIA events
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
NHS Solutions
-
Life Sciences Industry
-
Advancing UK Healthcare
-
Pharmacy Communications
NHS Solutions
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreNHS Solutions
Life Sciences Industry
We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreLife Sciences Industry Solutions
Advancing UK Healthcare
We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn MoreAdvancing UK Healthcare Solutions
Pharmacy Communications
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreBLOGS, WHITEPAPERS & CASE STUDIES
Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreOncology continues to be a hotbed of innovation, with over 100 new cancer treatments expected to launch in the next five years alone. This frantic activity makes oncology one of the key growth engines of the biopharmaceutical industry and underpins its status as the dominant therapy area, generating $223 billion of global sales in 2023, at ex-manufacturer prices.
However, achieving commercial success in oncology is becoming increasingly difficult. Innovators face overwhelming complexity, opportunity fragmentation and a widening ‘innovation readiness’ gap, as healthcare systems cannot keep up with the pace of oncology innovation to effectively adopt new therapies.
A panel of EMEA strategy consulting experts will discuss case study examples of how successful oncology launches have mastered three strategic pillars—healthcare system readiness, value and evidence, and stakeholder engagement.
Join us to explore the evolving oncology innovation landscape, learn how to navigate a challenging environment, and master launch excellence to fulfil the promise of ground-breaking transformational therapies.
3 key takeaways:
- There is an overwhelming pace of scientific advances in oncology with novel modalities like ADCs, bispecific antibodies and radiopharmaceuticals offering transformative potential for cancer care
- Oncology innovators face a highly complex and competitive environment, marked by rapid innovation, fragmented patient populations, and healthcare systems that are operationally and financially unprepared to adopt new products effectively
- Excellent oncology launches must master the three strategic pillars—healthcare system readiness, value and evidence, and stakeholder engagement
Speakers:
Dr. Stefan Lutzmayer
Senior Consultant, EMEA Thought Leadership, IQVIA
Kirstie Scott
Senior Consultant, EMEA Thought Leadership, IQVIA
Cristina Alzaga-Chaudhry
EMEA LEAD, Commercial Strategy & Transformation
Commercial Services, IQVIA
Parmender Dahiya
Associate Principal, Strategy Consulting EMEA, IQVIA